Other languages Clover Biopharmaceuticals, Ltd.

Equities

2197

KYG2280A1076

Market Closed - Hong Kong S.E. Other stock markets 04:08:05 2024-05-31 am EDT			5-day change	1st Jan Change
0.395 ^HKD	-.--%		-7.06%	-36.29%

Apr. 12	Clover Biopharmaceuticals, Ltd. announced that it has received $0.320713 million in funding	CI
Apr. 08	Clover Biopharmaceuticals' RSV Vaccine Candidate Shows Promise in Early Trial	MT

Other languages

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Clover Biopharmaceuticals, Ltd. announced that it has received $0.320713 million in funding	Apr. 11
Clover Biopharmaceuticals' RSV Vaccine Candidate Shows Promise in Early Trial	Apr. 08
Clover Announces Positive Preliminary Phase I Results for Bivalent RSV Vaccine Candidate SCB-1019 in Initial Young Adult Cohort	Apr. 08
Clover Biopharmaceuticals, Ltd. Announces Positive Preliminary Phase I Results for Bivalent RSV Vaccine Candidate SCB-1019 In Initial Young Adult Cohort	Apr. 08
Clover Biopharmaceuticals, Ltd. announced that it expects to receive $0.320713 million in funding	Apr. 01
Clover Biopharmaceuticals Trims Losses in 2023	Mar. 27
Clover Biopharmaceuticals, Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 26
Sinovac Halts Production of COVID-19 Vaccine as Demand Wanes	Jan. 12
Clover Announces Positive Phase ? Results for SCB-219M for Treatment of Chemotherapy-Induced Thrombocytopenia (CIT)	Dec. 29
Clover Biopharmaceuticals Publishes Positive Results from SCB-219M Clinical Trial	Dec. 29
Clover Biopharmaceuticals, Ltd. Announces Positive Phase I Results for SCB-219M for Treatment of Chemotherapy-Induced Thrombocytopenia	Dec. 28
Clover Biopharmaceuticals Completes Patient Enrollment for Australia Phase 1 Trial; Shares Fall 5%	Dec. 12
Clover Initiates Phase Ⅰ Clinical Trial for RSV Vaccine Candidate	Dec. 12
Clover Biopharmaceuticals, Ltd. Initiates Phase Clinical Trial for RSV Vaccine Candidate	Dec. 12
Clover Biopharmaceuticals Completes Submission of Application for Seasonal Flu Vaccine in Brazil	Nov. 06
Clover Biopharmaceuticals, Ltd. Completes Biologic License Application for Its Seasonal Influenza Vaccine in Brazil	Nov. 06
Clover Biopharmaceuticals Rolls Out Quadrivalent Seasonal Influenza Vaccine in Mainland China	23-09-11
Clover Launches Quadrivalent Seasonal Influenza Vaccine in Mainland China	23-09-11
Clover Launches Quadrivalent Seasonal Influenza Vaccine in Mainland China	23-09-11
Clover Launches Quadrivalent Seasonal Influenza Vaccine in Mainland China	23-09-11

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Clover Biopharmaceuticals, Ltd.

Equities

2197

KYG2280A1076

Other languages

Filters